VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SBRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SBRASabra Health Care REIT, Inc.
$19.54$4.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSBRAFinancials

Sabra Health Care REIT, Inc. (SBRA) Financials

16Y historyFree accessUpdated daily

Revenue growth reached 20.8% in 2026Q1, though operational headwinds caused NOI margins to contract to 61.4% from the 69.5% peak observed in 2023Q4.

SBRA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue812.84M774.63M703.24M647.51M624.81M569.54M598.57M668.18M623.41M405.65M260.53M238.86M183.52M134.78M103.17M84.22M8.8M
Revenue Growth %12.89%10.15%8.61%3.63%9.7%-4.85%-10.42%7.18%53.68%55.7%9.07%30.16%36.16%30.64%22.49%857.1%-
Property Operating Expenses296.81M271.11M227.09M195.25M162.61M141.2M131.55M109.71M49.55M17.86M5.7M2.58M3.91M0000
Net Operating Income (NOI)516.03M503.53M476.15M452.27M462.2M428.34M467.02M558.48M573.86M387.79M254.82M236.29M179.6M134.78M103.17M84.22M8.8M
NOI Margin %63.48%65%67.71%69.85%73.97%75.21%78.02%83.58%92.05%95.6%97.81%98.92%97.87%100%100%100%100%
Operating Expenses280.47M239.66M219.12M230.56M227.36M217.59M467.02M30.89M266.91M163.4M93.93M99.79M72.67M49.7M46.37M41.06M8.5M
G&A Expenses55.84M53.71M50.07M47.47M39.57M34.67M32.76M30.89M36.46M32.4M19.92M23.86M29.34M16.42M16.1M14.47M1.6M
EBITDA432.19M450.86M426.65M404.8M422.62M389.74M416.29M708.63M613.14M387.82M253.85M199.58M154.18M118.36M87.07M69.75M3.3M
EBITDA Margin %53.17%58.2%60.67%62.52%67.64%68.43%69.55%106.05%98.35%95.6%97.44%83.55%84.01%87.81%84.39%82.82%37.5%
Depreciation & Amortization196.63M187M169.62M183.09M187.78M178.99M176.74M181.04M306.19M163.43M92.96M63.08M43.33M33.28M30.26M26.59M3.1M
D&A / Revenue %24.19%24.14%24.12%28.28%30.05%31.43%29.53%27.09%49.11%40.29%35.68%26.41%23.61%24.69%29.33%31.57%35.23%
Operating Income235.56M263.87M257.03M221.71M234.84M210.75M0527.59M306.95M224.39M160.89M136.5M110.85M85.08M56.8M43.16M200K
Operating Margin %28.98%34.06%36.55%34.24%37.59%37%0%78.96%49.24%55.32%61.76%57.15%60.4%63.12%55.06%51.24%2.27%
Interest Expense4M112.49M115.27M112.96M105.47M98.63M100.42M126.61M147.11M88.44M64.87M59.22M46.96M40.46M37.01M30.32M0
Interest Coverage-2.40x2.11x1.14x0.28x-0.13x2.39x2.73x2.92x2.80x2.10x2.35x2.00x1.83x1.46x1.42x-
Non-Operating Income-5.94M-5.97M14.04M92.99M205.73M223.53M-239.55M181.55M-122.92M-14.93M27.01M4.92M16.98M10.9M2.96M0-3.91M
Pretax Income156.06M157.35M127.72M15.76M-76.36M-111.41M139.13M72.42M282.13M159.02M70.2M79.38M46.91M33.72M19.51M12.84M200K
Pretax Margin %19.2%20.31%18.16%2.43%-12.22%-19.56%23.24%10.84%45.26%39.2%26.95%33.23%25.56%25.01%18.91%15.25%2.27%
Income Tax1.95M1.84M1M2M1.24M1.84M710K3.4M3.01M651K75.48M61.45M0039.2M0242K
Effective Tax Rate %1.25%1.17%0.79%12.7%-1.63%-1.66%0.51%4.7%1.07%0.41%107.51%77.41%0%0%200.9%0%121%
Net Income156.19M155.61M126.71M13.76M-77.61M-113.26M138.42M69M279.08M158.38M70.28M79.41M46.95M33.72M19.51M12.84M7.38M
Net Margin %19.21%20.09%18.02%2.12%-12.42%-19.89%23.12%10.33%44.77%39.04%26.97%33.25%25.58%25.01%18.91%15.25%83.84%
Net Income Growth %10.96%22.81%821.14%117.73%31.48%-181.82%100.62%-75.28%76.21%125.37%-11.51%69.14%39.26%72.78%51.95%74.06%-
Funds From Operations (FFO)352.82M342.61M296.33M196.84M110.18M65.73M315.15M250.04M585.27M321.81M163.23M142.49M90.28M67M49.78M39.43M10.48M
FFO Margin %43.41%44.23%42.14%30.4%17.63%11.54%52.65%37.42%93.88%79.33%62.66%59.65%49.2%49.71%48.25%46.82%119.07%
FFO Growth %64.73%15.61%50.54%78.66%67.61%-79.14%26.04%-57.28%81.87%97.15%14.56%57.83%34.76%34.59%26.23%276.34%-
FFO per Share1.381.401.260.850.480.301.521.333.273.042.492.281.931.761.331.310.42
FFO Payout Ratio %61.82%84.5%94.54%140.95%251.56%399.97%88.31%134.15%55.57%56.58%73.06%77.13%90.26%86.8%98.3%80.24%0%
EPS (Diluted)0.610.640.540.06-0.34-0.520.670.371.561.400.921.110.780.680.520.430.29
EPS Growth %7.19%18.52%813.71%117.38%34.62%-177.61%81.08%-76.28%11.43%52.17%-17.12%42.31%14.71%30.77%20.93%48.28%-
EPS (Basic)-0.640.540.06-0.34-0.520.670.371.571.400.921.110.790.690.530.430.29
Diluted Shares Outstanding255.97M244.5M236.05M232.79M230.95M219.07M207.25M188.13M178.72M105.84M65.52M62.46M46.89M38.07M37.32M30.17M25.2M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowImproving
Top Statement Risk

Labor cost margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Expansion Amid Operational Complexity

According to the latest quarterly financial data, Sabra Health Care REIT achieved a 20.8% year-over-year revenue growth in 2026Q1, signaling a robust recovery in top-line performance that appears to be driven by a combination of inflationary rent escalators and improved occupancy within the managed portfolio segments.

The acceleration in revenue growth suggests that the company's strategic pivot toward high-acuity transitional care and behavioral health is beginning to yield tangible top-line results. However, investors should monitor whether this growth is sustainable or if it remains heavily reliant on one-time lease adjustments that may mask underlying volatility in the SHOP segment.

Margin Compression Reflects Operational Headwinds

As reported in the company's income statement, the NOI margin contracted to 61.4% in 2026Q1 from a peak of 69.5% in 2023Q4, indicating that rising property-level operating expenses are increasingly offsetting the gains realized from the company's diversified revenue streams across its various healthcare facility asset classes.

The downward trend in NOI margins suggests that the integration of managed senior housing assets is introducing significant variable cost exposure, particularly regarding labor. This shift warrants further investigation into whether the company can effectively pass these rising costs through to tenants or if they will continue to act as a persistent drag on profitability.

FFO Volatility Challenges Dividend Sustainability

Based on the provided financial figures, FFO per share reached $0.37 in 2026Q1, yet the historical data reveals significant quarterly fluctuations, including a notable 11.7% decline in 2025Q4, which suggests that the company's earnings quality remains sensitive to the inherent operational risks of its managed portfolio.

While the recent FFO growth appears positive, the inconsistency in quarterly performance may indicate that the company's earnings are susceptible to non-recurring items or timing differences in lease renewals. Analysts should remain cautious regarding the long-term safety of the dividend until the FFO trajectory demonstrates a more stable and predictable pattern.

GAAP Distortions Mask Cash Capacity

Financial statements indicate that GAAP net income of $40.9M in 2026Q1 significantly understates the company's true economic performance, as substantial non-cash depreciation charges continue to obscure the actual cash-generating capacity of the underlying real estate assets held within the diverse healthcare portfolio.

The reliance on GAAP net income as a performance metric is misleading for this REIT, as it fails to account for the recurring maintenance CAPEX required to keep healthcare facilities competitive. Investors should prioritize FFO and AFFO metrics to better understand the true cash flow available for distribution and reinvestment.

SBRA — Frequently Asked Questions

Quick answers to the most common questions about buying SBRA stock.

What was Sabra Health Care REIT, Inc.'s (SBRA) revenue in 2025?

For fiscal year 2025, Sabra Health Care REIT, Inc. (SBRA) reported total revenue of $774.6M. This represents a 8702.6% increase compared to $8.8M in 2010.

Is Sabra Health Care REIT, Inc. (SBRA) profitable?

Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $155.6M in net income for the fiscal year ending 2025 with a net profit margin of 20.1%.

What is Sabra Health Care REIT, Inc.'s operating profit margin?

Sabra Health Care REIT, Inc. (SBRA) reported an operating income of $263.9M, resulting in an operating profit margin of 34.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Sabra Health Care REIT, Inc.'s gross profit and gross margin?

Sabra Health Care REIT, Inc. (SBRA) generated $503.5M in gross profit for the year, representing a gross profit margin of 65.0%. This demonstrates the company's core pricing power and production efficiency.